文献速递呼吸道感染肺栓塞与肺血管病

呼吸衰竭与高血压的关联:来自COVID-19患者的证据

The liaison between respiratory failure and high blood pressure: evidence from COVID-19 patients.
PubMed 文献 · Eur Respir J · 2020-07-30

该文探讨COVID-19患者中呼吸衰竭与全身血压升高的关联,认为可能机制是SARS-CoV-2感染对肾素-血管紧张素-醛固酮系统的调节。文章基于COVID-19主要表现为低氧性正常或低碳酸血症且肺顺应性保留的特征,结合ACE2作为SARS-CoV-2刺突蛋白结合位点及RAAS counterpart的功能,提出呼吸衰竭与血压升高之间的可能联系。

要点

  • COVID-19呼吸衰竭与全身血压升高相关,机制可能涉及RAAS调节。
  • SARS-CoV-2通过ACE2结合,ACE2将Ang II转化为Ang-(1-7)并诱导血管舒张。
  • ACE2在肺、心、肾和胃肠道细胞外膜高表达,是病毒刺突蛋白结合位点。

核心结论

  • 在COVID-19患者中,呼吸衰竭与全身血压升高相关,可能由SARS-CoV-2感染调节RAAS所致。

主要发现

  • COVID-19主要表现为低氧性正常或低碳酸血症,且肺顺应性保留。
  • ACE2在肺、心、肾和胃肠道细胞外膜高表达,显示SARS-CoV-2刺突蛋白结合位点。
  • ACE2将Ang II转化为Ang-(1-7)、将Ang I转化为Ang-(1-9),其活性诱导血管舒张并减少细胞生长和炎症反应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In COVID-19 patients respiratory failure is associated with increased systemic blood pressure, conceivably due to the modulation of the renin-angiotensin-aldosterone system by SARS-CoV-2 infection https://bit.ly/3cINsHB Expanding from China around the world, coronavirus 2019 (COVID-19) is the disease caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). COVID-19 primarily manifests by hypoxic normo-hypocapnia with preserved lung compliance [1]. In the absence of targeted treatment, sub-intensive clinicians support patients with noninvasive ventilation and anti-inflammatory/anti-viral agents waiting for status improvement. Angiotensin-converting enzyme (ACE)2, highly expressed on the external membrane of lungs, heart, kidney and gastrointestinal tract cells, displays the binding site for the spike protein of SARS-CoV-2 [2]. ACE2, identified as a counterpart of the Renin-Angiotensin-Aldosterone System (RAAS), converts angiotensin (Ang) II to Ang-(1-7) and Ang I to Ang-(1-9). ACE2 activity induces vasodilatation and reduces cell growth and inflammatory response.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Vicenzi M, Di Cosola R, Ruscica M, et al. The liaison between respiratory failure and high blood pressure: evidence from COVID-19 patients. Eur Respir J. 2020. PMID: 32430432. doi:10.1183/13993003.01157-2020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。